Recent studies have explored aspirin’s potential role in reducing cancer risk, particularly for colorectal cancer. A cohort study published in JAMA Oncology analyzed over 30 years of data from 107,655 participants, revealing that regular aspirin users experienced an 18% lower risk of colorectal cancer compared to non-users. Notably, this protective effect was more pronounced in individuals with higher body mass indices, a history of smoking, and other poor lifestyle factors.
The anti-inflammatory properties of aspirin are believed to contribute to its potential cancer-preventive effects. However, it’s important to consider potential side effects, such as gastrointestinal bleeding. Experts advise consulting with a physician before beginning a regular aspirin regimen. Maintaining a healthy lifestyle and undergoing regular screenings remain the most effective strategies for reducing colorectal cancer risk. Click for More Details
